Atlas FDA

ABBOTT ARCHITECT AUSAB

FDA premarket approval P050051/S003 · decided 2008-11-13

Approval details

PMA number
P050051
Supplement
S003
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ABBOTT ARCHITECT AUSAB
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Abbott Laboratories, Inc.
Date received
2008-09-29
Decision date
2008-11-13
Days to decision
45 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
APPROVAL FOR CHANGE OF GRAYZONE RANGE AND CHANGES TO THE OUTPUT OF THE ASSAY FILE INTERPRETATION SCREEN.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30